Movement Disorders
Conference Coverage
Veterans Affairs Hailed as a ‘Bright Spot’ in ALS Care
Transdisciplinary collaboration is essential for maintaining an effective system.
FDA/CDC
FDA OKs Novel Levodopa-Based Continuous Sub-Q Regimen for Parkinson’s Disease
This new, non-surgical regimen provides continuous delivery of levodopa morning, day, and night.
Latest News
Parkinson’s Risk in Women and History of Migraine: New Data
Migraine was not associated with a higher risk for PD than that of nonmigraine headaches.
Latest News
Which Medications Can Cause Edema?
Nitrates, calclium channel blockers, neuropathic pain medications, and others can lead to edema.
Feature
How Clinicians Can Help Patients Navigate Psychedelics/Microdosing
Responding to patient inquiries about microdosing can be complicated, and clinicians must provide counsel on issues of legality and therapeutic...
Commentary
Undiagnosed, Untreated Tardive Dyskinesia, Hinders Adherence to Antipsychotics
It’s estimated that 50% of patients with tardive dyskinesia actually reduce the amount of antipsychotic medication they’re taking on their own.
Literature Review
Prodromal Parkinson’s Disease: Diagnostic Dilemma
Conference Coverage
TMS May Be a Good Alternative to ECT in Depression
A retrospective analysis shows better outcomes for TMS, but better population comparisons may be needed.
Conference Coverage
Major Gaps in Care and Management of Neurologic Diseases
Because many of these diseases are first detected during a visit with a primary care physician, it is important to understand the timeline from...
Conference Coverage
Environmental Chemicals Linked to Parkinson’s Disease in Urban Areas
A large, nationwide study is the first to show an association between TCE and Parkinson’s in the general population.
Hitting a Nerve
When the Next Big Thing Falls Short
Medicine, unfortunately, is littered with ideas that should have worked, but either didn’t, or at least aren’t as good as we thought they should...